Multifocal Breast Cancer

• Multifocal breast cancer involves multiple distinct tumor foci in one breast quadrant.
• It differs from multicentric breast cancer, which involves tumors in different quadrants.
• Symptoms are similar to unifocal breast cancer, often including a lump or skin changes.
• Treatment typically involves surgery, often mastectomy, followed by adjuvant therapies.
• Prognosis can vary, but advancements in treatment have improved outcomes.

What is Multifocal Breast Cancer?

Multifocal breast cancer refers to the presence of two or more distinct invasive tumor foci within the same quadrant of the breast. These tumors are believed to have originated from a single primary tumor that has spread locally within the breast tissue. It is important to differentiate multifocal breast cancer from multicentric breast cancer, where tumors are found in different quadrants of the breast, suggesting either independent origins or widespread dissemination. While less common than unifocal breast cancer, multifocal disease accounts for a significant percentage of diagnoses, with some studies indicating its incidence ranging from 6% to 20% of all breast cancer cases. (Source: American Cancer Society)

Multifocal Breast Cancer Symptoms

The multifocal breast cancer symptoms are generally similar to those of unifocal breast cancer, making early detection challenging without specific imaging. Often, the presence of multiple tumors is only confirmed after diagnostic imaging like mammography, ultrasound, or MRI, or upon pathological examination of biopsy samples. Patients may experience one or more of the following:

• A new lump or mass in the breast or armpit that may be painless.
• Changes in breast size or shape.
• Skin changes on the breast, such as dimpling, puckering, redness, or scaling.
• Nipple changes, including inversion, discharge (other than breast milk), or scaling.
• Pain in the breast or nipple, though this is less common.

It is crucial for individuals to perform regular self-examinations and seek medical attention for any persistent changes in their breasts, as early diagnosis significantly impacts treatment success.

Treatment and Prognosis for Multifocal Breast Cancer

The treatment for multifocal breast cancer is complex and typically involves a multidisciplinary approach tailored to the individual patient, considering factors such as tumor size, number of foci, lymph node involvement, hormone receptor status, and HER2 status. Surgical intervention is usually the primary step. Due to the presence of multiple tumor sites, mastectomy (removal of the entire breast) is often recommended to ensure complete removal of all cancerous tissue, although breast-conserving surgery (lumpectomy) followed by radiation therapy may be an option in select cases, depending on the extent and distribution of the disease.

Following surgery, adjuvant therapies are frequently employed to reduce the risk of recurrence. These may include:

• Radiation therapy: To target any remaining cancer cells in the breast area.
• Chemotherapy: Systemic treatment to kill cancer cells throughout the body.
• Hormone therapy: For hormone receptor-positive cancers, to block hormones that fuel cancer growth.
• Targeted therapy: For HER2-positive cancers or those with specific genetic mutations.

The prognosis of multifocal breast cancer has improved significantly due to advancements in diagnostic techniques and treatment modalities. While historically considered to have a slightly worse prognosis than unifocal breast cancer due to a higher likelihood of lymph node involvement and recurrence, recent studies suggest that when treated appropriately, the long-term outcomes can be comparable, especially for early-stage disease. Factors influencing prognosis include the biological characteristics of the tumors, the extent of lymph node involvement, and the patient’s overall health. Regular follow-up and adherence to post-treatment surveillance are vital for monitoring and managing potential recurrence.